STRATEC SE

STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS

STRATEC’S ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO € 0.97 PER SHARE

STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE

STRATEC SE: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2023 in Virtuelle Hauptversammlung mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

STRATEC SE: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2023 in Virtuelle Hauptversammlung mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR

STRATEC SE: Marcus Wolfinger, buy

STRATEC SE: Marcus Wolfinger, buy

STRATEC SE: Marcus Wolfinger, buy

STRATEC SE: Prof. Dr. Georg Heni, buy

STRATEC SE: Marcus Wolfinger, buy

STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023

STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE

STRATEC SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC SE: Dr. Claus Vielsack, Sale of 2,000 STRATEC shares previously acquired by exercising stock options in STRATEC SE. These stock options were granted to the individual in question from the …

STRATEC SE: Dr. Robert Siegle, Sale of 2,000 STRATEC shares previously acquired by exercising stock options in STRATEC SE. These stock options were granted to the individual in question from the …

STRATEC SE: Marcus Wolfinger, Sale of 3,500 STRATEC shares previously acquired by exercising stock options in STRATEC SE. These stock options were granted to the individual in question from the …

STRATEC SE: Dr. Claus Vielsack, Purchase of 2,500 STRATEC shares due to exercising of stock options in STRATEC SE. These stock options were granted to the individual in question from the stock …